Description

Levemir FlexPen Solution for Injections 100 IU/ml. 3 ml. Syringe №5

Ingredients:

Levemir FlexPen contains insulin detemir, glycerol, phenol, zinc, metacresol, and water for injections.

Dosage:

Levemir FlexPen is administered subcutaneously once or twice daily. Dosage is individualized based on the patient’s needs.

Indications:

Levemir FlexPen is indicated for the treatment of diabetes mellitus in adults, adolescents, and children aged 2 years and above.

Contraindications:

Levemir FlexPen is contraindicated in patients with hypersensitivity to insulin detemir or any of the excipients.

Directions:

Before each use, inspect the Levemir FlexPen visually for particulate matter and discoloration. Administer subcutaneously into the thigh, upper arm, or abdomen.

Scientific Evidence:

Studies have shown that Levemir FlexPen provides long-acting basal insulin coverage with a lower risk of hypoglycemia compared to other insulins. Research published in the Journal of Diabetes Science and Technology demonstrated the efficacy and safety of insulin detemir in managing diabetes.

Additional Information:

It is important to monitor blood glucose levels regularly while using Levemir FlexPen to adjust the dosage as needed. Consult a healthcare provider for proper usage instructions.

Pharmacologically, insulin detemir in Levemir FlexPen acts by lowering blood glucose levels through its interaction with insulin receptors on cells, promoting glucose uptake and utilization.

Clinical trials have shown that Levemir FlexPen offers consistent and predictable glucose-lowering effects, making it a valuable option for diabetes management.